Dendrimer and cancer: A patent review (2006-present)

Expert Opinion on Therapeutic Patents

Volumn 23, Issue 4, 2013, Pages 515-529

  Cai, Xiaopan ^b,c   Hu, Jingjing ^d   Xiao, Jianru ^b   Cheng, Yiyun ^a  

^a EAST CHINA NORMAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c Binhu Hospital   (China)

^d DALIAN UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

Anti cancer drug; Cancer; Cancer therapy; Dendrimer; Diagnosis; Targeting

Indexed keywords

CANCER VACCINE; CISPLATIN; CONTRAST MEDIUM; DENDRIMER; DENDRIMER PEPTIDE CONJUGATE; DNA; DOXORUBICIN; FOLIC ACID; GOLD NANOPARTICLE; MACROGOL; METHOTREXATE; PACLITAXEL; PENTETIC ACID; PEPTIDE; PHTHALOCYANINE; POLYAMIDOAMINE; POLYLYSINE; POLYPHENOL; POLYPROPYLENEIMINE; PRODRUG; PYROPHEOPHORBIDE; RADIOPHARMACEUTICAL AGENT; SMALL INTERFERING RNA; TETRAXETAN; TRIAZINE; UNCLASSIFIED DRUG;

CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER THERAPY; CHEMICAL MODIFICATION; CLICK CHEMISTRY; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG STRUCTURE; GENETIC TRANSFECTION; HUMAN; MALIGNANT NEOPLASTIC DISEASE; NEUTRON CAPTURE THERAPY; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTOTHERMAL THERAPY; REVIEW;

ANIMALS; ANTINEOPLASTIC AGENTS; DENDRIMERS; DRUG AND NARCOTIC CONTROL; HUMANS; MOLECULAR CONFORMATION; MOLECULAR TARGETED THERAPY; NEOPLASMS; PATENTS AS TOPIC; PREDICTIVE VALUE OF TESTS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84875167951     PISSN: 13543776     EISSN: 17447674     Source Type: Journal    
DOI: 10.1517/13543776.2013.761207     Document Type: Review

References (101)

1. Svenson S, Tomalia DA. Dendrimers in biomedical applications-reflections on the field. Adv Drug Deliv Rev 2005;57:2106-29
2. Tomalia DA. Interview: an architectural journey: from trees, dendrons/dendrimers to nanomedicine. Interview by Hannah Stanwix. Nanomedicine (Lond) 2012;7:953-6
3. Cheng Y, Xu T. The effect of dendrimers on the pharmacodynamic and pharmacokinetic behaviors of non-covalently or covalently attached drugs. Eur J Med Chem 2008;43:2291-7
4. Menjoge AR, Kannan RM, Tomalia DA. Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications. Drug Discov Today 2010;15:171-85
5. Cheng Y, Zhao L, Li Y, Xu T. Design of biocompatible dendrimers for cancer diagnosis and therapy: current status and future perspectives. Chem Soc Rev 2011;40:2673-703
6. Lim J, Simanek EE. Triazinedendrimers as drugdelivery systems: from synthesis to therapy. Adv Drug Deliv Rev 2012;64:826-35
7. Hu J, Su Y, Zhang H, et al. Design of interior-functionalized fully acetylated dendrimers for anticancer drug delivery. Biomaterials 2011;32:9950-9
8. Tekade RK, Kumar PV, Jain NK. Dendrimers in oncology: an expanding horizon. Chem Rev 2009;109:49-87
9. Liu H, Wang H, Yang W, Cheng Y. Disulfide cross-linked low generation dendrimers with high gene transfection efficacy, low cytotoxicity, and low cost. J Am Chem Soc 2012;134:17680-7
10. Kesharwan P, Gajbhiye V, Jain NK. A review of nanocarriers for the delivery of small interfering RNA. Biomaterials 2012;33:7138-50
11. Kobayashi H, Choyke PL. Methods for tumor treatment using dendrimer conjugates. US2006/0204443; 2006
12. Tomalia DA. Dendritic effects: dependency of dendritic nano-periodic property patterns on critical nanoscale design parameters (CNDPs). New J Chem 2012;36:264-81
13. Hong S, Eddington D, Myung JH, Launiere C. Methods and devices for capturing circulating tumor cells. US2012/0077246; 2012
14. Wei F, Liao W. Probe immobilization and signal amplification for polymer-based biosensor. US2010/0330706; 2010
15. Yin R, Qin D, Pan J. Symmetrically branched polymer conjugates and microarray assays. US2008/0114077; 2008
16. Yin R, Qin D, Pan J. Polymer conjugate enhanced bioassays. US2008/0200562; 2008
17. Weng KC. Nanoparticle labeling reagents and methods of use. US2011/0236957; 2011
18. Palent PD, Barto RR Jr, Borders TL, Stuart JA. Nano-getter device. WO086561; 2009
19. Palena PD, Barto RR Jr, Borders TL, Stuart JA. Nano-getter device. US8236243; 2012
20. Tao WA. Materials and methods for isolating phosphopeptides. US2010/0087008; 2010
21. Myc A, Majoros IJ, Thomas TP, Baker JR Jr. FRET-based apoptosis detector. US2008/0070266; 2008
22. Brechbiel MW, Xu H. Method of preparing macromolecular contrast agents and uses thereof. US2010/0056776; 2010
23. Krippner GY, Wu Z, Peter K, et al. Polylysine dendrimer contrast agent. US2010/0278750; 2010
24. Tomalia DA, Huang B. Encapsulated (chelate or ligand) dendritic polymers. US2008/0112891; 2008
25. Villaraza AJL, Bumb A, Brechbiel MW. Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics. Chem Rev 2010;110:2921-59
26. Brechbiel MW, Kobayashi H, Choyke PL, et al. Methods for imaging the lymphatic system using dendrimer-based contrast agents. EP1722825; 2006
27. Stewart M, Susumu K, Farrell D, Mattoussi HM. Metal oxide-chelating ligands. US8222449; 2012
28. Willard NP, Wegh RT, Pikkemaat JA, Gruell H. Responsive MRI contrast agents. US2008/0193384; 2008
29. Willard NP, Wegh RT, Pikkemaat JA, Gruell H. MRI contrast agents comprising CEST active paramagentic complex. EP1881852; 2009
30. Wegh RT, Pikkemaat JA, Willard NP. Method for using CEST contrast agents in MRI. EP1889086; 2010
31. Wegh RT, Pikkemaat JA, Willard NP. Method for using CEST contrast agents in MRI. US7917188; 2011
32. Tsourkas A, Cheng Z. Gadolinium-linked nanoclusters. US2012/0219496; 2012
33. Huang CH, Nwe K, Zaki AA, et al. Biodegradable polydisulfide dendrimer nanoclusters as MRI contrast agents. ACS Nano 2012;6:9416-24
34. Shi X, Baker JR Jr, Wang S. Functionalized dendrimer-encapsulated and dendrimer-stabilized nanoparticles. US2009/0208580; 2009
35. Ye JY, Norris TB, Baker JR Jr, Balogh LP. Laser-based method and system for enhancing optical breakdown. US7474919; 2009
36. Uchegbu I, Schatzlein AG, Dufes C. Bioactive polymers. US2008/0267903; 2008
37. Lee CY. Dendritic nano-antioxidants. US2010/0247439; 2010
38. Svenson S, Chauhan AS. Peham dendrimers as excipients. US2009/0324742; 2009
39. Sousa Hervesn A, Fernandez Megia E, Riguera Vega R. PH-sensitive dendritic polymeric micelles. US2012/0003322; 2012
40. Sousa Herves A, Fernandez Megia E, Riguera Vega R. PH-sensitive dendritic polymeric micelles. EP2322227; 2011
41. Sousa Hervesn A, Fernandez Megia E, Riguera Vega R. Dendritic pic micelles with bioactive proteins. US20120269895; 2012
42. Kissel T, Merkel OM, Mintzer M, Simanek E. Triazine dendrimers and methods of making and using the same for nucleic acid transport. US2010/0093094; 2010
43. Banerjee P, Reichardt W, Weissleder R, Bogdanov A. Hyperbranched dendron and methods of synthesis and use thereof. US7153905; 2006
44. Tack F, Janssen HM, Meijer EW, et al. Modified poly(propylene-imine) dendrimers and their use as transfection agents for amionic bioactive factors(as amended). US2010/0298403; 2010
45. Tack F, Janssen HM, Meijer EW, et al. Modified poly(propylene-imine) dendrimers and their use as transfection agents for anionic bioactive factors. WO006700; 2007
46. Gunaratne PH, Jayarathne LC, Anderson ML. Interior functionalized hyperbranched dendron-conjugated nanoparticles and uses threrof. US2012/0029062; 2012
47. Esuvaranathan K, Mahendran R, Lawrencia C. Methods and compositions for delivery of pharmaceutical agents. US7320963; 2008
48. Esuvaranathan K, Mahendran R, Lawrencia C. Methods and compositions for delivery of pharmaceutical agents. US7709457; 2010
49. Hawley-Nelson P, Lan J, Shih P, et al. Peptide-enhanced transfections. US8058068; 2011
50. Hawley-Nelson P, Lan J, Shih P, et al. Peptide-enhanced transfections. EP2206787; 2010
51. Weber M, Dennig J, Erbacher C. Targeted transfection of cells using a biotinylated dendrimer. US7192744; 2007
52. Weber M, Dennig J, Erbacher C. Targeted transfection of cells using a biotinylated dendrimer. EP1274462; 2008
53. Luo D, Li Y. Dendrimer-like modular delivery vector. US20120045430; 2012
54. Luo D, Li Y. Dendrimer-like modular delivery vector. US2010/0136614; 2010
55. Liskamp RMJ, Rijkers DTS, Pieters RJ, et al. Dendrimers multivalently substituted with active groups. US2008/0312344; 2008
56. Malik N, Duncan R, Tomalia DA, Esfand R. An antineoplastic- dendritic polymer drug delivery system. EP1439859; 2007
57. Huang A, Luo B, Wang J, Zhang Y. Liposome formulations of boronic acid compounds. US2009/0092662; 2009
58. Forrest L, Cohen M, Cai S. Intralymphatic chemotherapy drug carriers. US8088412; 2012
59. Li FQ, Chu YL, Zhu S, et al. Multifunctional carrier for the delivery of a pharmacological agent or genetic material into a cell. US7314956; 2008
60. Jacobson KA, Kim Y, Klutz A, et al. Dendrimer conjugates of agonists and antagonists of the GPCR superfamily. US8153781; 2012
61. Albrecht V, Wiehe A, Roeder B, Neuberger W. Photo-triggered release of active substances from dendrimer-photosensitizer complexes. US8153111; 2012
62. Baker JR Jr, Cheng XM, Van Der Spek AFL, et al. Dendrimer conjugates. US2010/0160299; 2010
63. Gingras M, Raimundo JM, Chabre YM, et al. Dendrimer-drug conjugates. US2008/0020043; 2008
64. De Groot FMH, Beusker PH, Scheeren JW. Prodrugs built as multiple self-elimination-release spacers. US7705045; 2010
65. Wilbur DS, Pathare PM, Hamlin DK, Wan F. Water soluble multi-biotin-containing compounds. US7141676; 2006
66. Krippner GY, Williams CC, Kelly BD, et al. Targeted polylysine dendrimer therapeutic agent. US2010/0292148; 2010
67. Majoros IJ, Thomas TP, Baker JR Jr, et al. Dendrimer based compositions and methods of using the same. WO033766; 2006
68. Nilsson R, Sandberg B, Wilbur S. Macromolecule conjugate. US2011/0014151; 2011
69. Baker JR Jr, Thomas TP, Shukla R. Dendrimer based compositions and methods of using the same. WO009203; 2009
70. Baker JR Jr, Shukla R, Thomas TP. Dendrimer based compositions and methods of using the same. US2009/0088376; 2009
71. Baker JR Jr, Zhang Y, Thomas TP, Desai AM. Synthesis of dendrimer conjugates. US2012/0177593; 2012
72. Baker JR Jr, Holl MMB, Desai A, et al. Synthesis and isolation of dendrimer systems. US20120232225; 2012
73. Majoros IJ, Thomas TP, Baker JR Jr, et al. Dendrimer based compositions and methods of using the same. EP1796537; 2007
74. Baker JR Jr, Baohua H. Dendrimer compositions and methods of synthesis. US20120259098; 2012
75. Shi X, Wang S, Baker JR Jr. Dendrimer based compositions and methods of using the same. WO008483; 2008
76. Shi XY, Wang SH, Baker JR Jr. Dendrimer based compositions and methods of using the same. US2009/0053139; 2009
77. William B, Shukla R, Baker JR Jr. Dendrimer based compositions and methods of using the same. US2007/0041934; 2007
78. Baker JR Jr, Zong H, Thomas TP. Multifunctional small molecules. US2012/0259114; 2012
79. Baker JR Jr, Banaszak Holl MM, Cheng X-m, et al. Dendrimer based modular platforms. US 2010/0158850; 2010
80. Baker JR Jr, Banaszak Holl MM, Cheng X-M, et al. Dendrimer based modular platforms. WO075423; 2010
81. Valentine AM, Dorahy D. Therapeutic agents. US2012/0244123; 2012
82. Agrez MV. Therapeutic peptides. WO103127; 2009
83. Livant D. Compounds for, and methods of, treating cancer and inhibiting invasion and metastases. US2012/0077755; 2012
84. Daftarian PM, Serafini P, Lemmon VP, et al. Compositions, kits and methods for in vitro antigen presentation, assessing immunotoxicity of biologics and drugs. US2012/0129199; 2012
85. Daftarian PM, Serafini P, Lemmon VP, et al. Vaccine compositions and methods of use thereof. WO115046; 2010
86. Bay S, Cantacuzene D, Leclerc C, Lo-Man R. Multiple antigen glycopeptide carbohydrate, vaccine comprising the same and use threreof. US7696326; 2010
87. Katti KV, Kannan R, Cutler CS. Gum arabic coated 198gold radioactive nanoparticles for cancer therapy. US2012/0134918; 2012
88. Khan MK, Minc LD, Nigavekar SS, et al. Fabrication of {198Au0} radioactive composite nanodevices and their use for nano-brachytherapy. Nanomedicine 2008;4:57-69
89. Ray A, Ghandehari H. Radiation enhanced macromolecular delivery of therapeutic agents for chemotherapy technology. US2012/0197060; 2012
90. Babich JW, Joyal JL, Zimmerman C. Psma-targeted dendrimers. WO078534; 2012
91. Tjarks W, Tiwari R, Byun Y, et al. Carboranyl thymidine analogues for neutron capture therapy. Chem Commun (Camb) 2007;4978-91
92. Josefsen LB, Boyle RW. Unique diagnostic and therapeutic roles of porphyrins and phthalocyanines in photodynamic therapy, imaging and theranostics. Theranostics 2012;2:916-66
93. Sakamoto K, Kanazawa S. Dendritic polyamidoamine phthalocyanine derivative. US8030342; 2011
94. Melancon MP, Zhou M, Li C. Cancer theranostics with near-infrared lightactivatable multimodal nanoparticles. Acc Chem Res 2011;44:947-56
95. Dykman L, Khlebtsov N. Gold nanoparticles in biomedical applications: recent advances and perspectives. Chem Soc Rev 2012;41:2256-82
96. Kadushin J, Getts RC. DNA dendrimers as thermal ablation devices. US2011/0206611; 2011
97. Wu P, Fokin VV, Sharpless KB. Method of using click chemistry to functionalize dendrimers. US2009/0306310; 2009
98. Wu P, Fokin VV, Sharpless KB. Method for making amphiphilic dendrimers. US2009/0182151; 2009
99. Harth EM, Calkins DJ, Ende AEVD. Multifunctional degradable nanoparticles with control over size and functionalities. US2011/0274620; 2011
100. Killops KL, Campos LM, Hawker CJ. Robust, efficient, and orthogonal synthesis of dendrimers via thiol-ene "click" chemistry. J Am Chem Soc 2008;130:5062-4
101. Walter MV, Malkoch M. Simplifying the synthesis of dendrimers: accelerated approaches. Chem Soc Rev 2012;41:4593-609